Zantut-Wittmann DE - Search Results

1

Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.

Oki GC, Zantut-Wittmann DE, de Oliveira Santos A, Guariento MH, Tambascia MA, de Almeida EA, Amorim BJ, Lima MC, Etchebehere EC, Camargo EE, Ramos CD. Oki GC, et al. Clin Nucl Med. 2010 Apr;35(4):223-7. doi: 10.1097/RLU.0b013e3181d18e8e. Clin Nucl Med. 2010. PMID: 20305407 Clinical Trial.

2

Thyroid suppression test with L-thyroxine and [99mTc] pertechnetate.

Ramos CD, Zantut-Wittmann DE, Tambascia MA, Assumpção L, Etchebehere EC, Camargo EE. Ramos CD, et al. Clin Endocrinol (Oxf). 2000 Apr;52(4):471-7. doi: 10.1046/j.1365-2265.2000.00898.x. Clin Endocrinol (Oxf). 2000. PMID: 10762290

3

Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.

Zantut-Wittmann DE, Tambascia MA, da Silva Trevisan MA, Pinto GA, Vassallo J. Zantut-Wittmann DE, et al. Thyroid. 2001 Jun;11(6):575-80. doi: 10.1089/105072501750302886. Thyroid. 2001. PMID: 11442005

4

Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals.

Ramos CD, Zantut Wittmann DE, Etchebehere EC, Tambascia MA, Silva CA, Camargo EE. Ramos CD, et al. Sao Paulo Med J. 2002 Mar 7;120(2):45-8. doi: 10.1590/s1516-31802002000200004. Sao Paulo Med J. 2002. PMID: 11994772 Free PMC article.

5

HLA-DRB1*04 and HLA-DQB1*03 association with the atrophic but not with the goitrous form of chronic autoimmune thyroiditis in a Brazilian population.

Zantut-Wittmann DE, Persoli L, Tambascia MA, Fischer E, Franco Maldonado D, Costa AM, João Pavin E. Zantut-Wittmann DE, et al. Horm Metab Res. 2004 Jul;36(7):492-500. doi: 10.1055/s-2004-825732. Horm Metab Res. 2004. PMID: 15305234 Clinical Trial.

6

99mTc-sestamibi thyroid uptake in euthyroid individuals and in patients with autoimmune thyroid disease.

Santos AO, Zantut-Wittmann DE, Nogueira RO, Etchebehere EC, Lima MC, Tambascia MA, Camargo EE, Ramos CD. Santos AO, et al. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):702-7. doi: 10.1007/s00259-004-1728-1. Epub 2005 Feb 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15703932 Clinical Trial.

7

High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease.

Zantut-Wittmann DE, Ramos CD, Santos AO, Lima MM, Panzan AD, Facuri FV, Etchebehere EC, Lima MC, Tambascia MA, Camargo EE. Zantut-Wittmann DE, et al. Nucl Med Commun. 2005 Nov;26(11):957-63. doi: 10.1097/01.mnm.0000183795.59097.42. Nucl Med Commun. 2005. PMID: 16208172

8

Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.

Garmes HM, Tambascia MA, Zantut-Wittmann DE. Garmes HM, et al. Gynecol Endocrinol. 2005 Dec;21(6):317-23. doi: 10.1080/09513590500430575. Gynecol Endocrinol. 2005. PMID: 16390779 Free article.

9

Pancytopenia in untreated patients with Graves' disease.

Lima CS, Zantut Wittmann DE, Castro V, Tambascia MA, Lorand-Metze I, Saad ST, Costa FF. Lima CS, et al. Thyroid. 2006 Apr;16(4):403-9. doi: 10.1089/thy.2006.16.403. Thyroid. 2006. PMID: 16646688

10

Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.

Neto AM, Tambascia MA, Brunetto S, Ramos CD, Zantut-Wittmann DE. Neto AM, et al. Cases J. 2009 Aug 25;2:8479. doi: 10.4076/1757-1626-2-8479. Cases J. 2009. PMID: 19918435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters